90 天前 - … poor prognosis despite immunotherapy. Few cases similar to ours have been
described in association with COVID-19 infection, with good outcome with immunotherapy. …

90 天前 - … successful application for the prevention of COVID-19. mRNA vaccine technology
won … As a promising new immunotherapy in CRC and other multiple cancer treatments, the …

92 天前 - … Notably, on a large-scale COVID-19 antigen-TCR binding test set, our method …
confirm that our approach effectively predicts immunotherapy response and clinical outcomes. …

94 天前 - … low as 14% despite immunotherapy and raised intracranial pressure measures [4].
We herein report a rare case of fulminant AHLE-COVID-19 with rapidly progressive global …

95 天前 - … of inflammation after vanco, which also normalized by first dose of immunotherapy.
… The study was limited by poor accrual during the COVID-19 pandemic. Nonetheless, …

95 天前 - … A total of 11 subjects were recruited, due to the COVID-19 pandemic and 100% CR
observed in … Further studies evaluating the role of intralesional immunotherapy should be …

96 天前 - … been extensively used in T cell analyses for COVID-19 patients and are currently
used in the development of immunotherapies for cancer. However, the immense diversity of …

96 天前 - … , for modulating cancer immunotherapy with targeted effects … COVID-19 symptoms
is examined, emphasizing their impact on the severity of and immune response to COVID-19. …

96 天前 - … Three (23%) children with acute necrotizing encephalopathy had poor prognoses
despite immunotherapy and other treatments. Ten (77%) children demonstrated good …

97 天前 - … COVID-19 spike protein antigens could be assembled onto ZMCP via coordination
with a high encapsulation efficacy. The self-adjuvanted ZMCP COVID-19 … immunotherapy, as …